retatrutide triple agonist glp-1 gip glucagon receptor just had its biggest data year yet. In 2026, Eli Lilly's GLP-1/GIP/glucagon posted two major Phase 3 readouts: TRIUMPH-1 (obesity, 2,339 participants) showed a 28.3% average body weight retatrutide triple agonist glp-1 gip

Description

Use a new needle for each injection

And, the best part

Combination Therapies : The integration of GLP-1 agonists with other weight loss agents is under exploration, aiming to create synergies that offer superior weight loss outcomes

Anderson, MD, MAS, an assistant professor of medicine from the University of Pittsburgh, clinical trials of several GLP-1 receptor agonists like semaglutide (Wegovy/Ozempic, Novo Nordisk) for weight loss included exclusion criteria of chronic medical and psychiatric conditions. However, [FDA] labeling does not restrict these treatments in these populations, they wrote in JAMA Internal Medicine